Protocol: Oral BPC-157 capsules are preferred over injectable for this stack because the target is the gastrointestinal lining
Ou T, Yamakawa-Kobayashi K, Arinami T, Amemiya M, Fujiwara H, Kawata K, Saito M, Kikuchi S, Noguchi Y, Sugishita Y, and Hamaguchi H (1998)
Peptide regulation of cell differentiation
(The 503A Bulks List is a list of drug substances that the FDA has approved for compounding.) The committee recommended six of those peptidesBPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semaxbe moved onto the list so that they can be legally prescribed and compounded in the future
Our mission is to empower health through responsibility and complex systems